speb/financial-data huggingface dataset:
Financial ratios for BRAP4.SA — quarterly report dated 2025-09-30
Total revenue: 105231766.91729322
Net income: 84205451.12781954
Capital expenditures: 0
Operating cash flow: 44748496.2406015
Net tangible assets: 1714209586.4661653
Owner earnings: 84205451.12781954
Return on net tangible assets (%): 4.912202789707218
Buffett classification: The Gruesome
Stock price: 2.8308270676691727
P/E ratio: 3.258921832530821
Shares outstanding: 255106712
Book value: 1714997368.4210525
P/B ratio: 0.42108693504209765
Market cap (USD): 722162985.4736842
Debt to equity: 0.00048740731095621925
Effective tax rate (%): 13.218508818150823
COGS to revenue (%): 0
SG&A to revenue (%): 0.25739818838832296
Free cash flow (dilution-adjusted): 44748496.2406015
Buyback yield (%): 0
Retained earnings: 228636466.16541353
Receivables turnover: 4.754460759751675
Capitalized R&D asset: 0
FCF margin (%): 42.523752619084625
Revenue growth (%): 24.048417898739856
Rule of 40 score: 66.57217051782447
Financial ratios for BRAP4.SA — annual report dated 2025-12-31
Total revenue: 117946897.81021897
Net income: 99816240.8759124
Capital expenditures: 0
Operating cash flow: 122265510.9489051
Net tangible assets: 1394836496.350365
Owner earnings: 99816240.8759124
Return on net tangible assets (%): 7.156124831626133
Buffett classification: The Gruesome
Stock price: 3.572710951526032
P/E ratio: 9.131004491576094
Shares outstanding: 255106712
Book value: 1395578649.6350362
P/B ratio: 0.6530785950390882
Market cap (USD): 911422543.7701974
Debt to equity: 0.0005661780406343235
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 5.344016932028981
Free cash flow (dilution-adjusted): 122265510.9489051
Buyback yield (%): 0
Receivables turnover: 1.0237570285895303
Capitalized R&D asset: 0
FCF margin (%): 103.6614893811238
Revenue growth (%): -42.210258922447466
Rule of 40 score: 61.451230458676335
Financial ratios for BRAP4.SA — quarterly report dated 2025-12-31
Total revenue: -128834489.05109487
Net income: -122144708.02919707
Capital expenditures: 0
Operating cash flow: 1328284.6715328465
Net tangible assets: 1394836496.350365
Owner earnings: -122144708.02919707
Return on net tangible assets (%): -8.75691942021826
Buffett classification: The Gruesome
Stock price: 3.572710951526032
P/E ratio: 9.164541736329431
Shares outstanding: 255106712
Book value: 1395578649.6350362
P/B ratio: 0.6530785950390882
Market cap (USD): 911422543.7701974
Debt to equity: 0.0005661780406343235
Free cash flow (dilution-adjusted): 1328284.6715328465
Buyback yield (%): 0
Receivables turnover: -1.1182592856577176
Capitalized R&D asset: 0
Revenue growth (%): -222.4292747572624
Rule of 40 score: -222.4292747572624
Financial ratios for CAVA — annual report dated 2023-12-31
Total revenue: 728700000
Gross profit: 180346000
Operating income: 31422000
Net income: 13280000
Capital expenditures: 138806000
Operating cash flow: 97101000
Depreciation & amortization: 47433000
Net tangible assets: 567503000
Owner earnings: -78093000
Return on net tangible assets (%): -13.760808312907596
Capex to operating income (%): 441.74781999872704
Buffett classification: The Gruesome
Stock price: 42.98
P/E ratio: 376.9613200963855
Shares outstanding: 116473856
Book value: 570802000
P/B ratio: 8.770197600709176
Market cap (USD): 5006046330.879999
Debt to equity: 0.5889923300899437
Current ratio: 3.2549983491690817
Quick ratio: 3.203299827579882
Effective tax rate (%): 5.466970387243736
COGS to revenue (%): 75.25099492246467
SG&A to revenue (%): 13.927679429120351
Free cash flow (dilution-adjusted): -51065000
Buyback yield (%): 0.062084922802815
Retained earnings: -447663000
Inventory turnover: 97.27762994500621
Receivables turnover: 61.31257888094236
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.592231122838025
FCF margin (%): -7.007684918347742
Revenue growth (%): 29.174872677573347
Rule of 40 score: 22.167187759225605
Financial ratios for CAVA — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 14325000
Buffett classification: The Gruesome
Stock price: 123.85
Shares outstanding: 116473856
Market cap (USD): 14425287065.599998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAVA — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 14975000
Buffett classification: The Gruesome
Stock price: 112.8
Shares outstanding: 116473856
Market cap (USD): 13138250956.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAVA — annual report dated 2024-12-31
Total revenue: 963713000
Gross profit: 241805000
Operating income: 60950000
Net income: 130319000
Capital expenditures: 108131000
Operating cash flow: 161027000
Depreciation & amortization: 60355000
Net tangible assets: 692267000
Owner earnings: 82543000
Return on net tangible assets (%): 11.923578619232176
Capex to operating income (%): 177.4093519278097
Buffett classification: The Gruesome
Stock price: 112.8
P/E ratio: 100.81608174402811
Shares outstanding: 116473856
Book value: 695566000
P/B ratio: 18.888575572699068
Market cap (USD): 13138250956.8
Debt to equity: 0.5444601950066564
Current ratio: 2.9716969751801923
Quick ratio: 2.9143972978678487
Effective tax rate (%): -117.52462026372892
COGS to revenue (%): 74.90902374462107
SG&A to revenue (%): 12.503722581307922
Free cash flow (dilution-adjusted): 39293000
Buyback yield (%): 0
Retained earnings: -317344000
Inventory turnover: 94.98789473684211
Receivables turnover: 74.15458602646969
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.8773443082332
FCF margin (%): 4.077251214832632
Revenue growth (%): 32.25099492246466
Rule of 40 score: 36.3282461372973
Financial ratios for CAVA — quarterly report dated 2025-03-31
Total revenue: 331826000
Gross profit: 84063000
Operating income: 21858000
Net income: 25707000
Capital expenditures: 35875000
Operating cash flow: 38577000
Depreciation & amortization: 20811000
Net tangible assets: 722651000
Owner earnings: 10643000
Return on net tangible assets (%): 1.4727717805690437
Capex to operating income (%): 164.12755055357306
Buffett classification: The Gruesome
Stock price: 86.41
P/E ratio: 97.87709473061811
Shares outstanding: 116473856
Book value: 726174000
P/B ratio: 13.859634050461734
Market cap (USD): 10064505896.96
Debt to equity: 0.5680332812796933
Current ratio: 3.0014224221391443
Quick ratio: 2.9472065416523927
Effective tax rate (%): -26.29949887000098
COGS to revenue (%): 74.66654210339154
SG&A to revenue (%): 12.47461018726682
Free cash flow (dilution-adjusted): -1781000
Buyback yield (%): 0
Retained earnings: -291637000
Inventory turnover: 34.03337912087912
Receivables turnover: 20.84727021423635
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.997833806331318
FCF margin (%): -0.5367270798551048
Rule of 40 score: -0.5367270798551048
Financial ratios for CAVA — quarterly report dated 2025-06-30
Total revenue: 280615000
Gross profit: 74681000
Operating income: 25815000
Net income: 18368000
Capital expenditures: 41119000
Operating cash flow: 60318000
Depreciation & amortization: 16815000
Net tangible assets: 747172000
Owner earnings: -5936000
Return on net tangible assets (%): -0.7944623192517921
Capex to operating income (%): 159.28336238620957
Buffett classification: The Gruesome
Stock price: 84.23
P/E ratio: 222.58860784753261
Shares outstanding: 116473856
Book value: 750709000
P/B ratio: 13.068436492542384
Market cap (USD): 9810592890.880001
Debt to equity: 0.5779030223428785
Current ratio: 2.722953411360576
Quick ratio: 2.670945370087244
Effective tax rate (%): 22.49789029535865
COGS to revenue (%): 73.38666856725406
SG&A to revenue (%): 11.421698768775725
Free cash flow (dilution-adjusted): 15177000
Buyback yield (%): 0
Retained earnings: -273269000
Inventory turnover: 25.761070803102328
Receivables turnover: 16.966866195054113
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2685989523053762
FCF margin (%): 5.408477807672433
Revenue growth (%): -15.433088425861746
Rule of 40 score: -10.024610618189312
Financial ratios for CAVA — quarterly report dated 2025-09-30
Total revenue: 292238000
Gross profit: 72366000
Operating income: 23239000
Net income: 14747000
Capital expenditures: 44270000
Operating cash flow: 45642000
Depreciation & amortization: 17628000
Net tangible assets: 765279000
Owner earnings: -11895000
Return on net tangible assets (%): -1.554335085635435
Capex to operating income (%): 190.49873058221095
Buffett classification: The Gruesome
Stock price: 60.41
P/E ratio: 119.61826597123523
Shares outstanding: 116473856
Book value: 769014000
P/B ratio: 9.149619696078355
Market cap (USD): 7036185640.96
Debt to equity: 0.576509660422307
Current ratio: 2.6857180762014266
Quick ratio: 2.6315204275669495
Effective tax rate (%): 28.641246491822315
COGS to revenue (%): 75.23730657888433
SG&A to revenue (%): 10.778543515901424
Free cash flow (dilution-adjusted): -1903000
Buyback yield (%): 0
Retained earnings: -258522000
Inventory turnover: 25.629094300034968
Receivables turnover: 16.98070889018013
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9970129450505631
FCF margin (%): -0.6511815711851299
Revenue growth (%): 4.141973878801918
Rule of 40 score: 3.490792307616788
Financial ratios for CAVA — quarterly report dated 2025-12-31
Total revenue: 274985000
Gross profit: 59357000
Operating income: 8432000
Net income: 4921000
Capital expenditures: 37435000
Operating cash flow: 40303000
Depreciation & amortization: 18407000
Net tangible assets: 775933000
Owner earnings: -14107000
Return on net tangible assets (%): -1.8180693436160082
Capex to operating income (%): 443.9634724857685
Buffett classification: The Gruesome
Stock price: 58.69
P/E ratio: 107.24080461603627
Shares outstanding: 116473856
Book value: 779656000
P/B ratio: 8.767777851565304
Market cap (USD): 6835850608.639999
Debt to equity: 0.5980175872436049
Current ratio: 2.6501964256072594
Quick ratio: 2.5947607542251485
Effective tax rate (%): 19.049185721335746
COGS to revenue (%): 78.41445897048929
SG&A to revenue (%): 11.825372293034166
Free cash flow (dilution-adjusted): -586000
Buyback yield (%): 0
Retained earnings: -253601000
Inventory turnover: 23.913496728401906
Receivables turnover: 14.482041289235307
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7042100603823379
FCF margin (%): -0.21310253286542905
Revenue growth (%): -5.903749683477166
Rule of 40 score: -6.116852216342595
Financial ratios for CAVA — annual report dated 2025-12-31
Total revenue: 1179664000
Gross profit: 290467000
Operating income: 79344000
Net income: 63743000
Capital expenditures: 158699000
Operating cash flow: 184840000
Depreciation & amortization: 73661000
Net tangible assets: 775933000
Owner earnings: -21295000
Return on net tangible assets (%): -2.7444379862694332
Capex to operating income (%): 200.01386368219397
Buffett classification: The Gruesome
Stock price: 58.69
P/E ratio: 107.24080461603627
Shares outstanding: 116473856
Book value: 779656000
P/B ratio: 8.767777851565304
Market cap (USD): 6835850608.639999
Debt to equity: 0.5980175872436049
Current ratio: 2.6501964256072594
Quick ratio: 2.5947607542251485
Effective tax rate (%): 9.96624246105171
COGS to revenue (%): 75.3771412876887
SG&A to revenue (%): 11.65264007378372
Free cash flow (dilution-adjusted): 10907000
Buyback yield (%): 0
Retained earnings: -253601000
Inventory turnover: 98.61339691693468
Receivables turnover: 62.12681693701285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.626523129859609
FCF margin (%): 0.9245853056463536
Revenue growth (%): 22.40822734569317
Rule of 40 score: 23.332812651339523
Financial ratios for CAVA — quarterly report dated 2026-03-31
Total revenue: 438270000
Gross profit: 111192000
Operating income: 34136000
Net income: 23566000
Capital expenditures: 48581000
Operating cash flow: 64065000
Depreciation & amortization: 25466000
Owner earnings: 451000
Capex to operating income (%): 142.31602999765641
Buffett classification: The Gruesome
Stock price: 80.9
P/E ratio: 152.96151018473427
Shares outstanding: 116473856
Market cap (USD): 9422734950.400002
Effective tax rate (%): 21.548653417224276
COGS to revenue (%): 74.6293380792662
SG&A to revenue (%): 11.771282542724805
Free cash flow (dilution-adjusted): 8812000
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): 2.010632714993041
Revenue growth (%): 59.379602523774025
Rule of 40 score: 61.39023523876707
Financial ratios for CCEL — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.93
Shares outstanding: 8062650
Market cap (USD): 80062114.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCEL — annual report dated 2022-11-30
Total revenue: 30336749
Gross profit: 21544391
Operating income: 4459800
Net income: 2771408
Capital expenditures: 10298459
Operating cash flow: 8572647
Depreciation & amortization: 1809342
Net tangible assets: -18620053
Owner earnings: -5717709
Capex to operating income (%): 230.91750751154757
Buffett classification: The Gruesome
Stock price: 3.99
P/E ratio: 11.60780855796043
Shares outstanding: 8062650
Book value: -1524302
Market cap (USD): 32169973.5
Debt to equity: -7.619303130219603
Current ratio: 0.4933000263841137
Quick ratio: 0.44960557289971675
Effective tax rate (%): 16.497396162880527
Interest coverage ratio: 2.9306720411206184
COGS to revenue (%): 28.982532043891716
R&D to revenue (%): 1.2683923382825233
SG&A to revenue (%): 51.35775755009213
Free cash flow (dilution-adjusted): -9057157
Buyback yield (%): 5.657185263146083
Retained earnings: -21637513
Inventory turnover: 10.329003911986185
Receivables turnover: 5.019365510020696
Capitalized R&D asset: 384789
ROCI (R&D-adjusted, %): 10.29958383254436
FCF margin (%): -29.85539749166926
Rule of 40 score: -29.85539749166926
Financial ratios for CCEL — annual report dated 2023-11-30
Total revenue: 31343695
Gross profit: 22953232
Operating income: 3490187
Net income: -9521669
Capital expenditures: 6838969
Operating cash flow: 8919754
Depreciation & amortization: 1710411
Net tangible assets: -13961764
Owner earnings: -14650227
Capex to operating income (%): 195.94849788850854
Buffett classification: The Gruesome
Stock price: 4.89
Shares outstanding: 8062650
Book value: -11031232
Market cap (USD): 39426358.5
Debt to equity: -0.9877437080463904
Current ratio: 0.4530692363367889
Quick ratio: 0.4162173880263905
Interest coverage ratio: 2.821963075500043
COGS to revenue (%): 26.769221050677018
R&D to revenue (%): 3.7374534176650203
SG&A to revenue (%): 54.77133758479975
Free cash flow (dilution-adjusted): 464147
Buyback yield (%): 2.026654325684174
Retained earnings: -31159182
Inventory turnover: 10.91262061422048
Receivables turnover: 4.766203027870029
Capitalized R&D asset: 1429264.63
ROCI (R&D-adjusted, %): 9.91454394391791
Rosenberg metric: 3.661333873889326
FCF margin (%): 1.4808305147175533
Revenue growth (%): 3.3192284380900534
Rule of 40 score: 4.800058952807607
Financial ratios for CCEL — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.66
Shares outstanding: 8062650
Market cap (USD): 45634599
Buyback yield (%): 0.03593764459286691
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCEL — annual report dated 2024-11-30
Total revenue: 31986106
Gross profit: 24038354
Operating income: 3788284
Net income: 402095
Capital expenditures: 2403708
Operating cash flow: 6010910
Depreciation & amortization: 1021597
Net tangible assets: -16078682
Owner earnings: -980016
Capex to operating income (%): 63.45110345475682
Buffett classification: The Good
Stock price: 8.15
P/E ratio: 163.42057847026203
Shares outstanding: 8062650
Book value: -13216017
Market cap (USD): 65710597.5
Debt to equity: -0.9786549154711287
Current ratio: 0.5812434819219778
Quick ratio: 0.550793623309235
Effective tax rate (%): 85.66056885562357
Interest coverage ratio: 2.0315957020063453
COGS to revenue (%): 24.84751347975899
R&D to revenue (%): 3.8846116498207066
SG&A to revenue (%): 57.912682462816825
Free cash flow (dilution-adjusted): 1626074
Buyback yield (%): 2.1668818336342173
Retained earnings: -32777626
Inventory turnover: 12.084104831512096
Receivables turnover: 4.376206681703642
Capitalized R&D asset: 2154391.89
ROCI (R&D-adjusted, %): 9.059624274806199
Rosenberg metric: 0.9263019695148601
FCF margin (%): 5.083688524011019
Revenue growth (%): 2.0495700969525132
Rule of 40 score: 7.133258620963533
Financial ratios for CCEL — quarterly report dated 2024-11-30
Total revenue: 8024345
Gross profit: 6387657
Operating income: -123382
Net income: -1861615
Capital expenditures: 8348
Operating cash flow: 2156993
Depreciation & amortization: 339448
Net tangible assets: -16078682
Owner earnings: -1530515
Buffett classification: The Gruesome
Stock price: 8.15
Shares outstanding: 8062650
Book value: -13216017
Market cap (USD): 65710597.5
Debt to equity: -0.9786549154711287
Current ratio: 0.5812434819219778
Quick ratio: 0.550793623309235
Interest coverage ratio: -0.16550501148241153
COGS to revenue (%): 20.39653080718738
R&D to revenue (%): 3.7963098545738005
SG&A to revenue (%): 74.90244998189883
Free cash flow (dilution-adjusted): 1865619
Buyback yield (%): 0
Retained earnings: -32777626
Inventory turnover: 2.488491005818736
Receivables turnover: 1.0978576824979949
Capitalized R&D asset: 304629
ROCI (R&D-adjusted, %): 0.18372292009353033
FCF margin (%): 23.249486406678677
Rule of 40 score: 23.249486406678677
Financial ratios for CCEL — quarterly report dated 2025-02-28
Total revenue: 7968880
Gross profit: 5984292
Operating income: 1056011
Net income: 282855
Capital expenditures: 62053
Operating cash flow: 954063
Depreciation & amortization: 339996
Net tangible assets: -17502007
Owner earnings: 560798
Return on net tangible assets (%): -3.204192524891574
Capex to operating income (%): 5.876169850503452
Buffett classification: The Great
Stock price: 7.67
P/E ratio: 54.65744418518322
Shares outstanding: 8062650
Book value: -14656309
Market cap (USD): 61840525.5
Debt to equity: -0.9457172334453374
Current ratio: 0.5758739059128183
Quick ratio: 0.5422457315494174
Effective tax rate (%): 47.002911649972454
Interest coverage ratio: 2.133519340878694
COGS to revenue (%): 24.904227444760117
R&D to revenue (%): 1.2315783397415947
SG&A to revenue (%): 58.204979871700914
Free cash flow (dilution-adjusted): 594618
Buyback yield (%): 0
Retained earnings: -34515310
Inventory turnover: 2.716875642568384
Receivables turnover: 1.1049496081869277
Capitalized R&D asset: 302244.43000000005
ROCI (R&D-adjusted, %): 2.3739817646191925
Rosenberg metric: -1.3241188462030864
FCF margin (%): 7.4617512122155185
Revenue growth (%): -0.6912090644158495
Rule of 40 score: 6.770542147799669
Financial ratios for CCEL — quarterly report dated 2025-05-31
Total revenue: 7928843
Gross profit: 6072304
Operating income: 1492634
Net income: 355785
Capital expenditures: 52592
Operating cash flow: 707014
Depreciation & amortization: 344259
Net tangible assets: -18388537
Owner earnings: 647452
Return on net tangible assets (%): -3.520954385876375
Capex to operating income (%): 3.5234357518319963
Buffett classification: The Great
Stock price: 5.12
P/E ratio: 29.006821535477886
Shares outstanding: 8062650
Book value: -15559805
Market cap (USD): 41280768
Debt to equity: -1.0133130203109872
Current ratio: 0.6000625488476112
Quick ratio: 0.5689506803301987
Effective tax rate (%): 38.13542965347077
Interest coverage ratio: 2.708335299006035
COGS to revenue (%): 23.415005190542935
R&D to revenue (%): 1.6611629212484091
SG&A to revenue (%): 53.70086152544577
Free cash flow (dilution-adjusted): 604580
Buyback yield (%): 0.21467381614605618
Retained earnings: -35370213
Inventory turnover: 2.743259097706143
Receivables turnover: 1.1438898854702477
Capitalized R&D asset: 297994.38
ROCI (R&D-adjusted, %): 3.3645249495357668
Rosenberg metric: 0.8967730760217234
FCF margin (%): 7.625072157438355
Revenue growth (%): -0.502416901747799
Rule of 40 score: 7.122655255690556
Financial ratios for CCEL — quarterly report dated 2025-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.7
Shares outstanding: 8062650
Market cap (USD): 37894455
Buyback yield (%): 0
Capitalized R&D asset: 120633.56000000001
Rule of 40 score: 0
Financial ratios for CCEL — annual report dated 2025-11-30
Total revenue: 31566321
Gross profit: 24189673
Operating income: 4841228
Net income: -2429385
Capital expenditures: 115475
Operating cash flow: 5478606
Depreciation & amortization: 1368118
Net tangible assets: -21410414
Owner earnings: -1176742
Capex to operating income (%): 2.3852419262220246
Buffett classification: The Great
Stock price: 4.3
Shares outstanding: 8062650
Book value: -18605929
Market cap (USD): 34669395
Debt to equity: -0.6212336400939722
Current ratio: 0.5940599566907208
Quick ratio: 0.5734064797799342
Interest coverage ratio: 2.342995253250323
COGS to revenue (%): 23.368728969080685
R&D to revenue (%): 1.1919760937614492
SG&A to revenue (%): 57.72198793771375
Free cash flow (dilution-adjusted): 4831030
Buyback yield (%): 0.4889095987974408
Retained earnings: -38438238
Inventory turnover: 18.044902811685102
Receivables turnover: 4.61079331831766
Capitalized R&D asset: 1595342.6
ROCI (R&D-adjusted, %): 9.849116361323505
Rosenberg metric: 0.12178238698918985
FCF margin (%): 15.304380893801339
Revenue growth (%): -1.312397951785691
Rule of 40 score: 13.991982942015648
Financial ratios for CCEL — quarterly report dated 2025-11-30
Total revenue: 7843166
Gross profit: 6109064
Operating income: 392047
Net income: -3817433
Capital expenditures: 67226
Operating cash flow: 1280813
Depreciation & amortization: 330233
Net tangible assets: -21410414
Owner earnings: -3554426
Capex to operating income (%): 17.147433853594084
Buffett classification: The Great
Stock price: 4.3
Shares outstanding: 8062650
Book value: -18605929
Market cap (USD): 34669395
Debt to equity: -0.6212336400939722
Current ratio: 0.5940599566907208
Quick ratio: 0.5734064797799342
Interest coverage ratio: 0.813461590334247
COGS to revenue (%): 22.10971946787815
R&D to revenue (%): 1.0809920381641802
SG&A to revenue (%): 69.4669346536845
Free cash flow (dilution-adjusted): 1170684
Buyback yield (%): 0
Retained earnings: -38438238
Inventory turnover: 4.241994745519748
Receivables turnover: 1.1456266122129422
Capitalized R&D asset: 128248.63
ROCI (R&D-adjusted, %): 0.9620296655238695
FCF margin (%): 14.926166295600526
Rule of 40 score: 14.926166295600526
Financial ratios for CEA.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.45454545454545
Shares outstanding: 8554496
Market cap (USD): 303295767.27272725
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEA.DE — annual report dated 2022-12-31
Total revenue: 196669148.93617022
Gross profit: 18782978.723404255
Operating income: 5486170.212765958
Net income: 544680.8510638298
Capital expenditures: 3471276.595744681
Operating cash flow: -2988297.872340426
Depreciation & amortization: 4686170.212765958
Net tangible assets: 22517021.276595745
Owner earnings: 1759574.468085107
Return on net tangible assets (%): 7.814419351790609
Capex to operating income (%): 63.27322086484389
Buffett classification: The Good
Stock price: 46.808510638297875
P/E ratio: 735.152
Shares outstanding: 8554496
Book value: 26502127.659574464
P/B ratio: 15.10909698137444
Market cap (USD): 400423217.0212766
Debt to equity: 1.5422286448298013
Current ratio: 1.2873382087451424
Quick ratio: 0.7075976867292924
Effective tax rate (%): 71.23595505617976
Interest coverage ratio: 1.9880493446414806
COGS to revenue (%): 90.44945339672957
SG&A to revenue (%): 6.914085108914961
Free cash flow (dilution-adjusted): -8162765.957446809
Buyback yield (%): 0
Retained earnings: -28047872.340425532
Inventory turnover: 4.412767529622886
Receivables turnover: 10.327877094972068
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.0207544311468
FCF margin (%): -4.150506574926029
Rule of 40 score: -4.150506574926029
Financial ratios for CEA.DE — annual report dated 2023-12-31
Total revenue: 123417777.77777778
Gross profit: 12295555.555555556
Operating income: -7263333.333333333
Net income: -12796666.666666666
Capital expenditures: 1996666.6666666665
Operating cash flow: 4620000
Depreciation & amortization: 4755555.555555555
Net tangible assets: 6350000
Owner earnings: -10037777.777777778
Return on net tangible assets (%): -158.07524059492565
Buffett classification: The Gruesome
Stock price: 33.111111111111114
Shares outstanding: 8554496
Book value: 10721111.11111112
P/B ratio: 26.41973062493521
Market cap (USD): 283248867.5555556
Debt to equity: 3.556948906622445
Current ratio: 1.3009796194122283
Quick ratio: 0.6765229140862515
Interest coverage ratio: -1.8980836236933798
COGS to revenue (%): 90.03745183477979
SG&A to revenue (%): 14.058842594259788
Free cash flow (dilution-adjusted): 1343333.3333333333
Buyback yield (%): 0
Retained earnings: -45058888.88888889
Inventory turnover: 3.606693353528797
Receivables turnover: 36.145785876993166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.375419494369446
FCF margin (%): 1.088443948287659
Revenue growth (%): -37.24598980298963
Rule of 40 score: -36.157545854701965
Financial ratios for CEA.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 739583.3333333334
Buffett classification: The Gruesome
Stock price: 23.75
Shares outstanding: 8554496
Book value: 3485416.6666666716
P/B ratio: 58.29124590555879
Market cap (USD): 203169280
Debt to equity: 9.874476987447686
Current ratio: 1.2027648730323395
Quick ratio: 0.7920932749988724
Buyback yield (%): 0
Retained earnings: -48888541.66666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEA.DE — annual report dated 2024-12-31
Total revenue: 96898958.33333334
Gross profit: 12468750
Operating income: -4011458.3333333335
Net income: -6509375
Capital expenditures: 651041.6666666667
Operating cash flow: 3241666.666666667
Depreciation & amortization: 3726041.666666667
Net tangible assets: 739583.3333333334
Owner earnings: -3434375
Return on net tangible assets (%): -464.3661971830985
Buffett classification: The Gruesome
Stock price: 23.75
Shares outstanding: 8554496
Book value: 3485416.6666666716
P/B ratio: 58.29124590555879
Market cap (USD): 203169280
Debt to equity: 9.874476987447686
Current ratio: 1.2027648730323395
Quick ratio: 0.7920932749988724
Interest coverage ratio: -1.0817415730337079
COGS to revenue (%): 87.1322146135902
SG&A to revenue (%): 16.286294787310663
Free cash flow (dilution-adjusted): 1756250
Buyback yield (%): 0
Retained earnings: -48888541.66666667
Inventory turnover: 4.451015925315761
Receivables turnover: 22.985668396342973
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.89975196362133
FCF margin (%): 1.8124549842512063
Revenue growth (%): -21.487033652634224
Rule of 40 score: -19.674578668383017
Financial ratios for CEA.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 9496470.588235294
Buffett classification: The Gruesome
Stock price: 10.470588235294118
Shares outstanding: 8554496
Market cap (USD): 89570605.1764706
Current ratio: 1.4114948731786294
Quick ratio: 0.9854535642447138
Buyback yield (%): 0
Retained earnings: -44931764.705882356
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEA.DE — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.411764705882353
Shares outstanding: 8554496
Market cap (USD): 71958407.52941176
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CFF.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.4724409448818898
Shares outstanding: 40767710
Market cap (USD): 60028045.43307087
Buyback yield (%): 18.77127834959485
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CFF.TO — annual report dated 2022-12-31
Total revenue: 170049117.6470588
Gross profit: 48195294.11764705
Operating income: 20193308.82352941
Net income: 18009338.235294115
Capital expenditures: 9945735.294117646
Operating cash flow: 18260073.529411763
Depreciation & amortization: 6174485.294117646
Net tangible assets: 103903602.94117646
Owner earnings: 14238088.235294117
Return on net tangible assets (%): 13.703170854772772
Capex to operating income (%): 49.2526280909882
Buffett classification: The Good
Stock price: 1.213235294117647
P/E ratio: 2.7463987841275155
Shares outstanding: 40767710
Book value: 107549485.29411764
P/B ratio: 0.45988899432750857
Market cap (USD): 49460824.63235294
Debt to equity: 0.4293570743426589
Current ratio: 2.72947493160505
Quick ratio: 1.2893742776469208
Effective tax rate (%): 27.931488025705235
Interest coverage ratio: 6.8093774019984625
COGS to revenue (%): 71.65801576361154
SG&A to revenue (%): 16.081728981418863
Free cash flow (dilution-adjusted): 7766102.941176469
Buyback yield (%): 1.141574887071016
Retained earnings: -107483161.76470588
Inventory turnover: 3.367112577614512
Receivables turnover: 22.27703392606007
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.310421154834042
FCF margin (%): 4.566976323449799
Rule of 40 score: 4.566976323449799
Financial ratios for CFF.TO — annual report dated 2023-12-31
Total revenue: 106938181.81818181
Gross profit: -4412121.212121212
Operating income: -29341969.696969695
Net income: -23203560.606060605
Capital expenditures: 5014318.181818182
Operating cash flow: 2745530.3030303027
Depreciation & amortization: 8890681.818181818
Net tangible assets: 83819772.72727272
Owner earnings: -19327196.96969697
Return on net tangible assets (%): -23.058040293884517
Buffett classification: The Gruesome
Stock price: 0.5
Shares outstanding: 40767710
Book value: 87502424.24242423
P/B ratio: 0.23295188877883904
Market cap (USD): 20383855
Debt to equity: 0.5527976714065065
Current ratio: 1.4505457346760804
Quick ratio: 0.8660541082011477
Interest coverage ratio: -8.180328215092825
COGS to revenue (%): 104.12586144359813
SG&A to revenue (%): 22.606943688792164
Free cash flow (dilution-adjusted): -2200606.0606060605
Buyback yield (%): 0.16427142208796364
Retained earnings: -133943787.87878788
Inventory turnover: 6.393485693406527
Receivables turnover: 19.578956128549038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.558021431449863
FCF margin (%): -2.057830068915488
Revenue growth (%): -37.11335683603212
Rule of 40 score: -39.171186904947604
Financial ratios for CFF.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.31111111111111106
Shares outstanding: 40767710
Market cap (USD): 12683287.555555554
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CFF.TO — annual report dated 2024-12-31
Total revenue: 89327552.44755246
Gross profit: 2682447.552447553
Operating income: -18086713.286713287
Net income: -20826013.986013986
Capital expenditures: 3734335.6643356644
Operating cash flow: -3745384.6153846155
Depreciation & amortization: 7802867.132867133
Net tangible assets: 56513146.85314686
Owner earnings: -16757482.517482517
Return on net tangible assets (%): -29.652361354125155
Buffett classification: The Gruesome
Stock price: 0.2097902097902098
Shares outstanding: 40767710
Book value: 60028881.11888112
P/B ratio: 0.14247585952216474
Market cap (USD): 8552666.433566434
Debt to equity: 0.9007086332569522
Current ratio: 1.5209374316526185
Quick ratio: 1.0360100270865928
Interest coverage ratio: -4.0008662562262165
COGS to revenue (%): 96.99706587838895
SG&A to revenue (%): 22.646753051549105
Free cash flow (dilution-adjusted): -7568111.888111888
Buyback yield (%): 0
Retained earnings: -144474685.3146853
Inventory turnover: 8.597295271929946
Receivables turnover: 17.21843449660992
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.850294175232781
FCF margin (%): -8.472315294382895
Revenue growth (%): -16.468046371473996
Rule of 40 score: -24.94036166585689
Financial ratios for CFF.TO — quarterly report dated 2024-12-31
Capital expenditures: 25174.825174825175
Buffett classification: The Gruesome
Stock price: 0.2097902097902098
Shares outstanding: 40767710
Market cap (USD): 8552666.433566434
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CFF.TO — quarterly report dated 2025-03-31
Total revenue: 31198251.74825175
Gross profit: 7547692.307692308
Operating income: 1622867.132867133
Net income: 439510.4895104895
Capital expenditures: 491188.8111888112
Operating cash flow: -4617622.377622378
Depreciation & amortization: 1932307.6923076925
Net tangible assets: 57638391.60839161
Owner earnings: 1880629.370629371
Return on net tangible assets (%): 3.262806817037498
Capex to operating income (%): 30.266729865988708
Buffett classification: The Good
Stock price: 0.24475524475524474
P/E ratio: 5.675695505171041
Shares outstanding: 40767710
Book value: 60584055.944055945
P/B ratio: 0.16469862711692243
Market cap (USD): 9978110.83916084
Debt to equity: 0.9716985705579256
Current ratio: 1.6292330046237111
Quick ratio: 0.9753355147187196
Interest coverage ratio: 1.0031555286591165
COGS to revenue (%): 75.80732289553612
SG&A to revenue (%): 18.99088840821724
Free cash flow (dilution-adjusted): -4680349.6503496505
Buyback yield (%): 0
Retained earnings: -143981958.04195803
Inventory turnover: 1.4564155785992352
Receivables turnover: 3.255485584606067
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2957572840632519
FCF margin (%): -15.001961289744134
Rule of 40 score: -15.001961289744134
Financial ratios for CFF.TO — quarterly report dated 2025-06-30
Total revenue: 24726423.35766423
Gross profit: 2224598.5401459853
Operating income: -3249999.9999999995
Net income: -6049562.04379562
Capital expenditures: 2348394.1605839413
Operating cash flow: 4950218.9781021895
Depreciation & amortization: 1411605.8394160583
Net tangible assets: 53793211.678832114
Owner earnings: -6986350.364963504
Return on net tangible assets (%): -12.987420060871111
Buffett classification: The Gruesome
Stock price: 0.2408759124087591
Shares outstanding: 40767710
Book value: 56866788.32116787
P/B ratio: 0.1726835580656548
Market cap (USD): 9819959.343065692
Debt to equity: 1.0478400667458205
Current ratio: 1.3579162307996904
Quick ratio: 0.8256827597619427
Interest coverage ratio: -1.8623473314371757
COGS to revenue (%): 91.00315274891366
SG&A to revenue (%): 22.140681088229737
Free cash flow (dilution-adjusted): 2917080.2919708025
Buyback yield (%): 0
Retained earnings: -156341094.89051095
Inventory turnover: 1.7115834124512106
Receivables turnover: 4.334527587265841
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6266360063570198
FCF margin (%): 11.797421122236916
Revenue growth (%): -20.744202088023027
Rule of 40 score: -8.946780965786111
Financial ratios for CFF.TO — quarterly report dated 2025-09-30
Total revenue: 27454676.258992806
Gross profit: -8975107.913669065
Operating income: -14044964.02877698
Net income: -11952877.697841728
Capital expenditures: 148992.8057553957
Operating cash flow: 223884.89208633095
Depreciation & amortization: 2266043.165467626
Net tangible assets: 41146402.87769785
Owner earnings: -9835827.338129498
Return on net tangible assets (%): -23.90446466818782
Buffett classification: The Gruesome
Stock price: 0.18705035971223025
Shares outstanding: 40767710
Book value: 44162158.27338129
P/B ratio: 0.17267305580805864
Market cap (USD): 7625614.820143886
Debt to equity: 1.345349219847065
Current ratio: 1.102976170907923
Quick ratio: 0.7024967062090173
Interest coverage ratio: -4.4562761076491135
COGS to revenue (%): 132.69063466275352
SG&A to revenue (%): 18.466275352444843
Free cash flow (dilution-adjusted): 15611.510791366905
Buyback yield (%): 0
Retained earnings: -166039496.40287772
Inventory turnover: 3.197491885884596
Receivables turnover: 3.5977110103419343
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.80730192944831
FCF margin (%): 0.056862847859126875
Revenue growth (%): 11.03375470792836
Rule of 40 score: 11.090617555787487
Financial ratios for CFF.TO — annual report dated 2025-12-31
Total revenue: 104196788.32116787
Gross profit: -7248248.175182481
Operating income: -27463211.678832114
Net income: -26033941.605839413
Capital expenditures: 3304379.5620437954
Operating cash flow: 3433284.6715328465
Depreciation & amortization: 7947445.255474452
Net tangible assets: 32709999.999999996
Owner earnings: -21390875.912408754
Return on net tangible assets (%): -65.3955240367128
Buffett classification: The Gruesome
Stock price: 0.051094890510948905
Shares outstanding: 40767710
Book value: 36306861.31386861
P/B ratio: 0.057372672917789164
Market cap (USD): 2083021.6788321168
Debt to equity: 1.7621772241477753
Current ratio: 0.3313566732869663
Quick ratio: 0.2222115905443151
Interest coverage ratio: -3.1821880153930726
COGS to revenue (%): 106.95630670768956
SG&A to revenue (%): 19.165657907272596
Free cash flow (dilution-adjusted): 445036.49635036493
Buyback yield (%): 0
Retained earnings: -176835985.40145984
Inventory turnover: 11.639212666854709
Receivables turnover: 23.709801185908614
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.00878360150524
FCF margin (%): 0.42711152955945236
Revenue growth (%): 16.645744192247626
Rule of 40 score: 17.07285572180708
Financial ratios for CFF.TO — quarterly report dated 2025-12-31
Total revenue: 19050218.97810219
Gross profit: -8305912.408759124
Operating income: -11718029.197080292
Net income: -8372554.744525547
Capital expenditures: 1317591.2408759124
Operating cash flow: 3075693.430656934
Depreciation & amortization: 2219708.02919708
Net tangible assets: 32709999.999999996
Owner earnings: -7470437.956204379
Return on net tangible assets (%): -22.838391795183064
Buffett classification: The Gruesome
Stock price: 0.051094890510948905
Shares outstanding: 40767710
Book value: 36306861.31386861
P/B ratio: 0.057372672917789164
Market cap (USD): 2083021.6788321168
Debt to equity: 1.7621772241477753
Current ratio: 0.3313566732869663
Quick ratio: 0.2222115905443151
Interest coverage ratio: -5.785325597318822
COGS to revenue (%): 143.60008889297592
SG&A to revenue (%): 16.625285453737334
Free cash flow (dilution-adjusted): 1884598.5401459853
Buyback yield (%): 0
Retained earnings: -176835985.40145984
Inventory turnover: 2.857048110568164
Receivables turnover: 4.334844785490059
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.351028563851436
FCF margin (%): 9.892792005762717
Revenue growth (%): -30.612115770761385
Rule of 40 score: -20.71932376499867
Financial ratios for CGX.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.716535433070865
Shares outstanding: 63466340
Market cap (USD): 680139281.4173228
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGX.TO — annual report dated 2022-12-31
Total revenue: 810941911.7647058
Gross profit: 532569852.9411764
Operating income: 29038235.294117644
Net income: 83088.23529411764
Capital expenditures: 40444852.94117647
Operating cash flow: 78785294.11764705
Depreciation & amortization: 134542647.05882353
Net tangible assets: -682629411.7647058
Owner earnings: 94180882.35294116
Return on net tangible assets (%): -13.79678061475092
Capex to operating income (%): 139.28137344272258
Buffett classification: The Gruesome
Stock price: 5.919117647058823
P/E ratio: 4521.274663716814
Shares outstanding: 63466340
Book value: -155745588.2352941
Market cap (USD): 375664733.08823526
Debt to equity: -9.090650287516407
Current ratio: 0.398258903291367
Quick ratio: 0.3266679853854925
Interest coverage ratio: 0.32346364596899035
COGS to revenue (%): 34.32700354798025
SG&A to revenue (%): 25.38097945290562
Free cash flow (dilution-adjusted): 26365441.176470585
Buyback yield (%): 0
Retained earnings: -844830882.3529412
Inventory turnover: 10.255336439484234
Receivables turnover: 10.106954665004903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.415705388175448
FCF margin (%): 3.251212052796267
Rule of 40 score: 3.251212052796267
Financial ratios for CGX.TO — annual report dated 2023-12-31
Total revenue: 1052192424.2424242
Gross profit: 702208333.3333333
Operating income: 113026515.15151514
Net income: 126639393.93939394
Capital expenditures: 39756060.6060606
Operating cash flow: 158432575.75757575
Depreciation & amortization: 133740909.09090908
Net tangible assets: -561066666.6666666
Owner earnings: 220624242.4242424
Return on net tangible assets (%): -39.32228655375043
Capex to operating income (%): 35.174101008746945
Buffett classification: The Good
Stock price: 6.34090909090909
P/E ratio: 3.1777970484075513
Shares outstanding: 63466340
Book value: -29875000
Market cap (USD): 402434292.2727272
Debt to equity: -48.07589704577153
Current ratio: 0.5448673419663871
Quick ratio: 0.5083223605768733
Interest coverage ratio: 0.9629335605209826
COGS to revenue (%): 33.26236559449461
SG&A to revenue (%): 24.880948438109744
Free cash flow (dilution-adjusted): 105643939.39393939
Buyback yield (%): 0
Retained earnings: -743918939.3939394
Inventory turnover: 26.21306173399909
Receivables turnover: 13.826031556418299
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.3384705324113
FCF margin (%): 10.04036305146397
Revenue growth (%): 29.749419653588845
Rule of 40 score: 39.789782705052815
Financial ratios for CGX.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.007407407407408
Shares outstanding: 63466340
Market cap (USD): 508200841.0370371
Buyback yield (%): 0.29749101728496935
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGX.TO — annual report dated 2024-12-31
Total revenue: 891437762.2377623
Gross profit: 590787412.5874126
Operating income: 61833566.433566436
Net income: -26350349.65034965
Capital expenditures: 50039860.139860146
Operating cash flow: 113295804.1958042
Depreciation & amortization: 114898601.3986014
Net tangible assets: -518274125.8741259
Owner earnings: 38508391.608391605
Capex to operating income (%): 80.92669245210469
Buffett classification: The Gruesome
Stock price: 8.531468531468532
Shares outstanding: 63466340
Book value: -27762237.762237787
Market cap (USD): 541461082.5174825
Debt to equity: -46.23783375314858
Current ratio: 0.42854283535018584
Quick ratio: 0.39117381355519615
Interest coverage ratio: 0.6228304970134114
COGS to revenue (%): 33.72645431753214
SG&A to revenue (%): 26.893931073868256
Free cash flow (dilution-adjusted): 53525874.12587413
Buyback yield (%): 0.8570439483819428
Retained earnings: -711687412.5874126
Inventory turnover: 20.745512449334107
Receivables turnover: 10.443512313414494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.103016032411095
FCF margin (%): 6.004443203248308
Revenue growth (%): -15.278066853637048
Rule of 40 score: -9.273623650388739
Financial ratios for CGX.TO — quarterly report dated 2024-12-31
Total revenue: 253666433.56643358
Operating income: 30947552.44755245
Net income: 2330069.9300699304
Capital expenditures: 15934265.734265735
Operating cash flow: 73953846.15384616
Depreciation & amortization: 30004195.804195806
Net tangible assets: -518274125.8741259
Owner earnings: 16400000.000000002
Return on net tangible assets (%): -3.1643485910741944
Capex to operating income (%): 51.48796746130381
Buffett classification: The Good
Stock price: 8.531468531468532
P/E ratio: 58.09493907563025
Shares outstanding: 63466340
Book value: -27762237.762237787
Market cap (USD): 541461082.5174825
Debt to equity: -46.23783375314858
Current ratio: 0.42854283535018584
Quick ratio: 0.39117381355519615
Effective tax rate (%): -5.077262693156732
Interest coverage ratio: 1.2324551631948313
COGS to revenue (%): 0
SG&A to revenue (%): 26.946626123729473
Free cash flow (dilution-adjusted): 55424475.52447553
Buyback yield (%): 0.5934473994597689
Retained earnings: -711687412.5874126
Inventory turnover: 0
Receivables turnover: 2.971793023217709
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5540473469764655
FCF margin (%): 21.849353398962904
Rule of 40 score: 21.849353398962904
Financial ratios for CGX.TO — quarterly report dated 2025-03-31
Total revenue: 176030069.93006992
Gross profit: 119095104.8951049
Operating income: -7600000
Net income: -25604895.104895107
Capital expenditures: 11846153.846153846
Operating cash flow: -15848951.04895105
Depreciation & amortization: 28580419.58041958
Net tangible assets: -541897902.0979022
Owner earnings: -8870629.370629372
Buffett classification: The Gruesome
Stock price: 6.916083916083917
Shares outstanding: 63466340
Book value: -51844755.24475503
Market cap (USD): 438938533.2867133
Debt to equity: -24.482734899781594
Current ratio: 0.248100763074947
Quick ratio: 0.20963857457937926
Interest coverage ratio: -0.3169529586747937
COGS to revenue (%): 32.34388593811452
SG&A to revenue (%): 32.15121383425432
Free cash flow (dilution-adjusted): -30757342.657342657
Buyback yield (%): 0
Retained earnings: -737292307.6923077
Inventory turnover: 4.4719872569482595
Receivables turnover: 3.8175131560988187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6515185213383106
FCF margin (%): -17.472777616665937
Revenue growth (%): -30.6056905302101
Rule of 40 score: -48.078468146876034
Financial ratios for CGX.TO — quarterly report dated 2025-06-30
Total revenue: 264099270.07299268
Gross profit: 173574452.5547445
Operating income: 24017518.24817518
Net income: -1604379.5620437956
Capital expenditures: 5589781.02189781
Operating cash flow: 40723357.66423357
Depreciation & amortization: 31763503.649635036
Net tangible assets: -566815328.4671532
Owner earnings: 24569343.06569343
Capex to operating income (%): 23.273766107464137
Buffett classification: The Great
Stock price: 8.467153284671532
Shares outstanding: 63466340
Book value: -55176642.335766554
Market cap (USD): 537379229.1970803
Debt to equity: -24.71457297068467
Current ratio: 0.31335250436352946
Quick ratio: 0.27711800610164267
Interest coverage ratio: 0.9119733924611974
COGS to revenue (%): 34.27681473456121
SG&A to revenue (%): 27.21134499303513
Free cash flow (dilution-adjusted): 32810948.905109487
Buyback yield (%): 0
Retained earnings: -771186861.3138685
Inventory turnover: 7.137373388581953
Receivables turnover: 5.10902441435208
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8997767311992602
FCF margin (%): 12.423718132973667
Revenue growth (%): 50.030770412071824
Rule of 40 score: 62.45448854504549
Financial ratios for CGX.TO — quarterly report dated 2025-09-30
Gross profit: 162927338.12949643
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.589928057553957
Shares outstanding: 63466340
Market cap (USD): 545171294.676259
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGX.TO — annual report dated 2025-12-31
Total revenue: 937785401.4598539
Gross profit: 622445255.4744525
Operating income: 69018978.10218978
Net income: -27177372.26277372
Capital expenditures: 29610218.97810219
Operating cash flow: 102758394.16058393
Depreciation & amortization: 116829197.08029196
Net tangible assets: -535609489.05109483
Owner earnings: 60041605.83941604
Capex to operating income (%): 42.90156097973687
Buffett classification: The Good
Stock price: 7.693430656934305
Shares outstanding: 63466340
Book value: -58023357.664233446
Market cap (USD): 488273885.83941597
Debt to equity: -22.563905801841745
Current ratio: 0.5209874077437759
Quick ratio: 0.49102639229880757
Interest coverage ratio: 0.6677777934716592
COGS to revenue (%): 33.626045521129925
SG&A to revenue (%): 27.206121581673244
Free cash flow (dilution-adjusted): 64047445.25547445
Buyback yield (%): 1.0684143617878399
Retained earnings: -768532846.7153285
Inventory turnover: 27.169108861077923
Receivables turnover: 11.337904620706695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.7072944312292035
FCF margin (%): 6.829648356198717
Revenue growth (%): 5.1992007951004675
Rule of 40 score: 12.028849151299184